Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-05-22
1991-06-04
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514212, A61K 3155
Patent
active
050214101
ABSTRACT:
Methods and pharmaceutical formulations of alpha.sub.2 agonists and alpha.sub.3 antagonists which are useful in lowering intraocular pressure (IOP) and treatment of intraocular hypertension. Co-administration of a therapeutic amount of alpha.sub.2 agonist with a potentiating amount of alpha.sub.3 agonist is effective in lowering IOP and treatment of intraocular hypertension.
REFERENCES:
patent: 4496558 (1985-01-01), Demarinis et al.
Chem. Abst. 104:45623n (1986), Van Pinxteren.
Allergan Inc.
Fay Zohreh A.
Friedman Stanley J.
Lambert Howard R.
Voet Martin A.
LandOfFree
Combinations of selective alpha-adrenergic agonists and antagoni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations of selective alpha-adrenergic agonists and antagoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of selective alpha-adrenergic agonists and antagoni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1026481